Sitara Peroxide Limited (PSX: SPL) reported a financial turnaround for the fiscal year ended June 30, 2026, recording a net profit of Rs147.46 million compared to a net loss of Rs222.52 million in FY25.
Earnings per share (EPS) turned positive at Rs2.68 against a loss per share (LPS) of Rs4.04 in the previous year. The turnaround was primarily driven by a massive spike in other income along with tax credit provisioning, which offset higher finance costs and operational overheads.
| Description (PKR) | FY26 | FY25 | Change (%) |
|---|---|---|---|
| Other Income | 375,722,952 | 12,900,000 | 2812.6% |
| Administrative Expenses | (240,405,328) | (254,749,594) | -5.6% |
| Finance Cost | (38,725,966) | (4,735,314) | 717.8% |
| Profit / (Loss) Before Tax | 14,091,658 | (311,354,016) | - |
| Taxation Provision | 133,367,601 | 88,835,172 | 50.1% |
| Net Profit / (Loss) | 147,459,259 | (222,518,844) | - |
| EPS / (LPS) (Rs) | 2.68 | (4.04) | - |
Investor Takeaway: Although finance costs expanded significantly to Rs38.73 million, the surge in non-operating income (Rs375.72m) and tax benefits (Rs133.37m) helped SPL close FY26 back in the black.
Read the full story on the original publisher’s website.
Open original article